Inovio Pharmaceuticals, Inc. (INO) — Stock Score Summary

Inovio Pharmaceuticals, Inc. (INO) has a MoatMap StockRank of 1/100 based on Quality (11/100), Value (32/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. Biotech firm with a history of clinical delays and shareholder dilution, lacking any structural competitive advantage or commercialized products.

Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing DNA medicines for infectious diseases, cancer, and other unmet medical needs using its proprietary CELLECTRA® delivery platform. The company utilizes a unique DNA plasmid technology and electroporation delivery system, aiming to generate robust and durable immune responses for therapeutic and prophylactic purposes. Inovio is a clinical-stage biopharmaceutical company with a broad pipeline, representing a speculative investment based on the success of its novel DNA medicine platform.

Key Financial Metrics

Price$1.10
Market Cap$107M
P/E (Forward)-2.40
Price/Book3.32
Return on Equity-296.4%
Return on Invested Capital-277.2%
Debt/Equity143.30
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-34M

Inovio Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Inovio Pharmaceuticals, Inc.’s (INO) StockRank?
MoatMap’s StockRank for Inovio Pharmaceuticals, Inc. (INO) is 1/100, with a Strong Sell signal. It is a composite of Quality (11), Value (32), and Momentum (19) factor ranks across MoatMap’s 19,000+ stock universe.
Does Inovio Pharmaceuticals, Inc. have an economic moat?
Inovio Pharmaceuticals, Inc. (INO) has a Quality factor score of 11/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Inovio Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Inovio Pharmaceuticals, Inc. (INO) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Inovio Pharmaceuticals, Inc. in?
Inovio Pharmaceuticals, Inc. (INO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksINO deep dive reportAI ChampionsHow we score stocksSense-check another stock